Filing Flows › Stemtech (STEK) › Q4 2024
Stemtech (STEK) Q4 2024 earnings results (fourth quarter 2024)
10-K filed Jun 30, 2025
Stemtech (STEK) reported revenue of $1.3M for the fourth quarter 2024 (Q4 2024), -4% from a year earlier and +27% from the quarter before. Operating margin was 2.5%, net loss $397K (30.2% of revenue).
Stemtech, Q4 2024: revenue $1.3M (-4% year over year), operating margin 2.5%, net loss $397K, operating cash flow −$271K. The chart follows the revenue to costs, profit and cash.
| Q4 2024 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.3M | +27% | -4% |
| Operating profit | $33K | — | — |
| Net earnings | −$397K | — | — |
| Operating cash flow | −$271K | — | — |
What changed
Revenue was $1.3M in Q4 2024, down 4% year over year and up 27% from the previous quarter.
Gross margin was 79.6%, down 4.3 points from a year earlier. Operating profit was $33K, a 2.5% margin (up 107.3 points year over year). Operating expenses fell 61% while revenue fell 4%. The quarter ended with a net loss of $397K, narrower than the previous quarter's $1.2M loss. Net interest and other expense of $430K was the main reason.
Operating cash flow was −$271K. Non-cash charges added back $185K of depreciation and amortization and $209K of share-based compensation. Working capital and other items used $268K.
Questions
What was Stemtech's revenue in the fourth quarter 2024?
Stemtech (STEK) reported revenue of $1.3M for the fourth quarter 2024 (Q4 2024), -4% from a year earlier and +27% from the quarter before.
Was Stemtech profitable in the fourth quarter 2024?
Operating profit was $33K (2.5% of revenue) and net loss $397K.
Source: Stemtech 10-K on SEC EDGAR.